The POSITIVE trial assessed the safety of pausing endocrine therapy for pregnancy in HR-positive early breast cancer patients. Breastfeeding did not increase short-term breast cancer recurrence risk, ...

Please provide your email address to receive an email when new articles are posted on . Women who breastfeed after undergoing treatment for breast cancer are not at elevated risk for recurrence or new ...

Please provide your email address to receive an email when new articles are posted on . Women who breastfed after breast cancer did not have an increased risk for recurrence or contralateral disease.

Jennifer Deming, 60, was diagnosed with stage II, hormone receptor-positive, HER2-negative breast cancer in 2020. She opted for a double mastectomy. Still, she worried about the cancer coming back. “I ...

Dr. Elisa Port draws on patient stories like Martin's and Evert's and 25 years of experience for a new book on breast care ...